Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125192261 | 12519226 | 1 | I | 20150512 | 20160701 | 20160701 | PER | KR-LUPIN PHARMACEUTICALS INC.-2015-01501 | LUPIN | KIM M, WEE W, LEE J. ADVERSE EFFECTS OF LOW-DOSE SYSTEMIC CYCLOSPORINE THERAPY IN HIGH-RISK PENETRATING KERATOPLASTY. GRAEFES ARCH CLIN EXP OPHTHALMOL. 2015 APR 21;. | 65.00 | YR | F | Y | 0.00000 | 20160624 | OT | KR | KR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125192261 | 12519226 | 1 | PS | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | UNKNOWN | 78103 | ||||||||||
| 125192261 | 12519226 | 2 | C | CYCLOSPORINE. | CYCLOSPORINE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125192261 | 12519226 | 1 | Hypercholesterolaemia |
| 125192261 | 12519226 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125192261 | 12519226 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125192261 | 12519226 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |